Clinical Trial Results: A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating monthly long-acting GA Depot injections for efficacy, safety, and tolerability in relapsing-remitting multiple sclerosis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GA Depot (GA Depot)

Snippet

Sponsor: Mapi Pharma Ltd. | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: COMPLETED | Results posted: 2026-08-05